Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2007; 13(29): 3996-4001
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.3996
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.3996
Variable | Group A | Group B | Group C | Group D | |
(n = 45) | (n = 48) | (n = 58) | (n = 98) | ||
Age (yr) | 35 ± 9 | 38 ± 12 | 48 ± 12 | 57 ± 12 | |
Gender (M:F) | 22/23 | 22/27 | 42/16 | 64/34 | |
BMI | 28.0 ± 6.3 | 33.3 ± 20.6 | 30.0 ± 6.4 | 26.9 ± 5.3 | |
HR/min | Baseline | - | 78 ± 12 | 85 ± 14 | 84 ± 17 |
End | - | 86 ± 13 | 94 ± 17 | 92 ± 19 | |
O2 % | Baseline | - | 98.1 ± 1.0 | 96.7 ± 9.3 | 97.8 ± 1.75 |
End | - | 98.2 ± 0.76 | 98.1 ± 1.1 | 97.1 ± 2.8 | |
BS | Baseline | - | 0.11 ± 0.45 | 0.07 ± 0.24 | 0.66 ± 1.34 |
End | - | 0.53 ± 0.73 | 0.98 ± 1.34 | 1.68 ± 2.00 | |
6MWD (m) | 421 ± 47 | 390 ± 53 | 357 ± 72 | 306 ± 111 | |
Hemoglobin (g/L) | - | 128.7 ± 44.1 | 136.2 ± 20.3 | 94.9 ± 54.6 | |
Albumin (g/L) | - | 37.9 ± 6.1 | 37.6 ± 6.3 | 28.3 ± 6.8 | |
ALT (U/L) | - | 128.5 ± 232.2 | 89.7 ± 54.2 | 86.2 ± 63.1 | |
AST (U/L) | - | 55.8 ± 70.2 | 56.4 ± 34.0 | 94.8 ± 76.9 | |
GGT (U/L) | - | 47.7 ± 50.0 | 101.6 ± 83.3 | 164.6 ± 225.2 | |
ALP (U/L) | - | 96.7 ± 36.4 | 102.8 ± 42.1 | 180.7 ± 129.4 | |
Bilirubin (μmol/L) | - | 11.1 ± 6.3 | 14.9 ± 12.8 | 44.0 ± 58.9 | |
Creatinine (μmol/L) | - | 70.3 ± 21.4 | 68.0 ± 16.6 | 86.8 ± 39.1 |
Variable | Non-survivors (n = 15) | Survivors (n = 83) | P | |
Age (yr) | 61 ± 10 | 55 ± 11 | 0.064 | |
CP score | 10.0 ± 2.3 | 8.5 ± 2.2a | 0.016 | |
6MWD (m) | 245 ± 145 | 317 ± 101a | 0.021 | |
O2% | Baseline | 97.3 ± 1.7 | 97.9 ± 1.5 | 0.21 |
End | 97.4 ± 3.0 | 97.2 ± 1.6 | 0.64 | |
Hemoglobin (g/L) | 114.7 ± 14.7 | 127.6 ± 17.7b | 0.009 | |
Prothrombin time (s) | 16.1 ± 5.6 | 16.5 ± 4.5 | 0.82 | |
ALT (U/L) | 90.5 ± 82.7 | 85.4 ± 59.5 | 0.77 | |
AST (U/L) | 107.1 ± 62.6 | 92.3 ± 79.4 | 0.50 | |
ALP (U/L) | 242.2 ± 141.8 | 169.5 ± 124.7 | 0.45 | |
Albumin (g/L) | 24.2 ± 5.6 | 29.0 ± 6.6a | 0.011 | |
Bilirubin (μmol/L) | 67.4 ± 65.1 | 40.1 ± 56.9 | 0.098 | |
Creatinine (μmol/L) | 114.4 ± 86.0 | 81.7 ± 18.0b | 0.002 |
Variable | Hazard ratio (95% CI) | P | |
UV | CP Score | 1.349 (1.062-1.713) | 0.014 |
UV | 6MWD | 0.995 (0.991-0.999) | 0.027 |
UV | Albumin | 0.901 (0.829-0.978) | 0.013 |
UV | Hemoglobin | 0.966 (0.941-0.992) | 0.012 |
UV | ALP | 1.003 (1.000-1.005) | 0.042 |
UV | Creatinine | 1.016 (1.007-1.024) | < 0.0001 |
MV | 6MWD | 0.994 (0.989-0.998) | 0.024 |
MV | ALP | 1.003 (1.000-1.006) | 0.027 |
MV | Creatinine | 1.018 (1.009-1.027) | < 0.0001 |
- Citation: Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA. Six Minute Walk Test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 2007; 13(29): 3996-4001
- URL: https://www.wjgnet.com/1007-9327/full/v13/i29/3996.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i29.3996